未確診的睡眠障礙：成長機會 是由出版商Koncept Analytics在2008年04月所出版的。
這份英文市場調查報告書包含31 pages 價格從美金900起跳。
Abstract
There are more than 70 different sleep disorders but the most common ones
include insomnia, sleep apnea, restless legs syndrome, and narcolepsy. One of
the fastest growing sector in the sleep disorder treatment market is
obstructive sleep apnea (OSA) products. OSA affects up to 18 million patients
in the US with as many as 85% are undiagnosed. Similarly, 30 million are
chronic sufferers of insomnia but only a third of chronic sufferers are
receiving treatment. A key reason for this low percentage of people receiving
treatment is the side effects associated with most of the insomnia drugs. Over
1.6 million Americans use some form of alternative medicine to treat insomnia.
With rising awareness of sleep disorders, more people are undergoing tests to
understand the basics of their sleep disorder condition. Hospitals are opening
new sleep centers and upgrading old ones. Patients are looking at innovative
aspects in sleep centers which make them feel more homely.
Pharma companies are coming up with new sleeping disorder drugs. Gamma
Aminobutyric Acid (GABA) agents dominate the insomnia market. More than a
dozen insomnia drugs are in phase II and phase III clinical trials. Major
products are Ambien, Ambien CR, Lunesta, Temazepam, and Zolpidem. Respironics
and ResMed are the leading competitors in the continuous positive airway
pressure (CPAP) market.
The report analyzes the sleep disorder treatment market. The focus is on OSA
and insomnia treatment products. The report also profiles the major companies,
with a discussion of their key business strategies. It also analyzes the major
market and demographic trends prevalent in the sleep disorder treatment market.
Table of Contents
1. Sleep Disorders: An Introduction
- 1.1 Sleep Cycle
- 1.2 Amount of Sleep Required
- 1.3 Sleep Disorders
- 1.4 Insomnia
- 1.5 Sleep Apnea
- 1.6 Narcolepsy
- 1.7 Restless Legs Syndrome
- 1.8 Treatment & Diagnosis
2. Market Overview
- 2.1 Worldwide Market
- 2.2 US Market
3. OSA Market
- 3.1 Sleep Disordered Breathing Market Breakup
- 3.2 US Market for OSA Treatment
4. Insomnia Market
5. Market Trends
- 5.1 Use of Actigraphy for Sleep Disorder Evaluation
- 5.2 Alternative Medicines for Insomnia
- 5.3 Opportunities for HME Providers
- 5.4 Increasing Sleep Centers
6. Demographic Trends
- 6.1 Sleep Disorders in Older People
- 6.2 Sleep Disorders in Women
- 6.3 Sleep Disorders in Children
- 6.4 Sleep Concerns of Employees
7. Competitive Landscape
- 7.1 Insomnia Market
- 7.1.1 Drugs in Pipeline for Insomnia
- 7.1.2 Insomnia Market Activity
- 7.1.3 Marketers of Insomnia Drugs
- 7.1.4 Insomnia Market Share
- 7.1.5 Characteristics of Drugs
- 7.2 OSA Market
- 7.2.1 OSA Sales & Market Share
- 7.2.2 Worldwide Market
- 7.2.3 US Market
8. Company Profiles
- 8.1 Respironics
- 8.1.1 Overview
- 8.1.2 Business Strategies
- 8.1.3 Product Innovation
- 8.1.4 Strong Distribution Network
- 8.1.5 International Growth
- 8.2 ResMed
- 8.2.1 Overview
- 8.2.1 Business Strategies
- 8.2.1 Continued Product Development and Innovation
- 8.2.1 Increase Public and Clinical Awareness
- 8.2.1 Expansion into New Clinical Applications
- 8.3 Neurocrine
- 8.3.1 Overview
- 8.3.2 Business Strategies
- 8.3.3 Building Product Portfolio
- 8.3.4 Identifying Novel Drug Targets
- 8.4 Neurogen
- 8.4.1 Overview
- 8.4.2 Business Strategies
- 8.4.3 Pursue a Risk-balanced Drug Portfolio
- 8.4.4 Partnering at Optimal Stages
- 8.4.5 Focus on Specialist Care Indications
List of Charts
- Total Sleep/Day by Age Group
- Classification of Sleep Disorders
- Worldwide Market for Sleep Disorder Treatment (2004-10E)
- US Sleep Diagnostic/Treatment Device Market (2005-07E)
- US Market for OSA Treatment (2003-07E)
- Sleep Disordered Breathing Market Breakup
- Insomnia Market Share - Drug Classes (2006)
- Non-Benzo/Non-Barbituate Market Share (2007)
List of Tables
- Sleep Disorder Facilities in the US (1996-2007)
- Employees Survey - Causes of Sleep Disturbance
- Drugs in Pipeline for Insomnia
- Insomnia Market Activity (2007)
- Current/Potential Marketers of Insomnia Drugs
- Characteristics of Drugs Marketed For Insomnia
- OSA Market Leaders - Market Share (2005-09E)
- OSA Market Leaders -US & International Sales (2005-09E)
- ResMed - CPAP Products
- Neurocrine - Product Pipeline
- Neurogen - Clinical Development Programs
